These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 12516400

  • 1. [Expression of autoantibodies to ICA512 and GAD in the sera of patients with diabetic ketoacidosis or ketonemia].
    Zhang YJ, Chen HL, Yu LP, Han XY.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec 28; 25(6):545-7. PubMed ID: 12516400
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y, Kawasaki E, Abiru N, Ozaki M, Abe T, Takino H, Kondo H, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S, Uchigata Y, Matsuura N, Eguchi K.
    J Autoimmun; 1999 Sep 28; 13(2):257-65. PubMed ID: 10479394
    [Abstract] [Full Text] [Related]

  • 3. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
    Mayrhofer M, Rabin DU, Messenger L, Standl E, Ziegler AG.
    Exp Clin Endocrinol Diabetes; 1996 Sep 28; 104(3):228-34. PubMed ID: 8817240
    [Abstract] [Full Text] [Related]

  • 4. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S, Willis J, Maclean C, Ananieva-Jordanova R, Amoroso MA, Brooking H, Powell M, Collins A, Bennett S, Mitchell S, Burne P, Furmaniak J, Smith BR.
    Clin Chim Acta; 2005 Jul 01; 357(1):74-83. PubMed ID: 15963796
    [Abstract] [Full Text] [Related]

  • 5. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE.
    J Autoimmun; 2005 Mar 01; 24(2):153-67. PubMed ID: 15829408
    [Abstract] [Full Text] [Related]

  • 6. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.
    Diabet Med; 1997 Aug 01; 14(8):678-85. PubMed ID: 9272595
    [Abstract] [Full Text] [Related]

  • 7. Dual-parameter model for prediction of type I diabetes mellitus.
    Eisenbarth GS, Gianani R, Yu L, Pietropaolo M, Verge CF, Chase HP, Redondo MJ, Colman P, Harrison L, Jackson R.
    Proc Assoc Am Physicians; 1998 Aug 01; 110(2):126-35. PubMed ID: 9542768
    [Abstract] [Full Text] [Related]

  • 8. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
    Miao D, Yu L, Tiberti C, Cuthbertson DD, Rewers M, di Mario U, Eisenbarth GS, Dotta F.
    J Autoimmun; 2002 Mar 01; 18(2):191-6. PubMed ID: 11908951
    [Abstract] [Full Text] [Related]

  • 9. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA.
    J Autoimmun; 1999 Sep 01; 13(2):267-82. PubMed ID: 10479395
    [Abstract] [Full Text] [Related]

  • 10. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
    Leslie RD, Atkinson MA, Notkins AL.
    Diabetologia; 1999 Jan 01; 42(1):3-14. PubMed ID: 10027571
    [No Abstract] [Full Text] [Related]

  • 11. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T.
    J Autoimmun; 1999 Mar 01; 12(2):131-5. PubMed ID: 10047433
    [Abstract] [Full Text] [Related]

  • 12. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B, Zimmy S, Schatz H, Pfohl M.
    Med Klin (Munich); 2003 Feb 15; 98(2):67-71. PubMed ID: 12601530
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulation with human recombinant autoantigens.
    Lernmark A, Agardh CD.
    Trends Immunol; 2005 Nov 15; 26(11):608-12. PubMed ID: 16153889
    [Abstract] [Full Text] [Related]

  • 14. Antibodies directed against the ectodomain of ICA512: is there any evidence in patients with diabetes mellitus?
    Schiel R.
    Diabetologia; 1998 Dec 15; 41(12):64-5. PubMed ID: 9867225
    [No Abstract] [Full Text] [Related]

  • 15. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S, Kanaani J, Jaume JC, Kash S.
    J Autoimmun; 2000 Nov 15; 15(3):279-86. PubMed ID: 11040068
    [No Abstract] [Full Text] [Related]

  • 16. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.
    Metabolism; 2003 Jan 15; 52(1):25-9. PubMed ID: 12524658
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
    Park Y, Lee H, Takino H, Abiru N, Kawasaki E, Eisenbarth GS.
    Acta Diabetol; 2001 Jan 15; 38(1):51-6. PubMed ID: 11487177
    [Abstract] [Full Text] [Related]

  • 18. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
    Gupta M, Graham J, McNeeny B, Zarghami M, Landin-Olsson M, Hagopian WA, Palmer J, Lernmark A, Sanjeevi CB.
    Ann N Y Acad Sci; 2006 Oct 15; 1079():229-39. PubMed ID: 17130560
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to ICA512/IA-2 in rodent models of IDDM.
    Myers MA, Laks MR, Feeney SJ, Mandel TE, Koulmanda M, Bone A, Barley J, Rowley MJ, Mackay IR.
    J Autoimmun; 1998 Jun 15; 11(3):265-72. PubMed ID: 9693975
    [Abstract] [Full Text] [Related]

  • 20. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren.
    Kulmala P, Rahko J, Savola K, Vähäsalo P, Veijola R, Sjöroos M, Reunanen A, Ilonen J, Knip M.
    Diabetologia; 2000 Apr 15; 43(4):457-64. PubMed ID: 10819239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.